Anna Martinez Cardús
机构: Health Sciences Research Institute of the Germans Trias i Pujol Foundation (IGTP). B-ARGO group
每年引用次数
引用次数
引用: 4,095
H-指数: 34
I10-指数 : 42
出版物: 114
120P Prognostic significance of SAMHD1 expression in breast cancer
V. Quiroga , E. Felip , I. Teruel , A. Martinez-Cardús
Annals of Oncology 32
2021
Pharmacogenetic analysis of TS and UGT1A polymorphisms predictive for response and toxicity in Spanish patients with advanced colorectal cancer treated with first-line irinotecan and 5-fluorouracil
E. Martinez-Balibrea , A. Abad , M. Valladares , M. Martinez-Villacampa
Journal of Clinical Oncology 27 4066 -4066
3
2009
3011 ORAL Role of Thymidylate synthase –6bp/1494 deletion polymorphism in capecitabine or 5-fluorouracil (5FU) selection in first line oxaliplatin-based chemotherapy in advanced colorectal cancer
E. Martinez-Balibrea , E. Aranda , J.L. Manzano , J. Sastre
Ejc Supplements 5 ( 4) 238
2007
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
C. Plasencia , E. Martínez-Balibrea , A. Martinez-Cardús , D. Quinn
International Journal of Oncology 29 ( 1) 225 -235
57
2006
1001 CDK5 is Involved in Oxaliplatin Response and Resistance Acquisition Through Regulation of STAT3 Transcription Factor
V. Ruiz de Porras , C. Alcon , A. Martinez-Cardús , A. Ginés
European Journal of Cancer 48
1
2012
Use of a proteomic approach to link pyruvate kinase M2 expression to oxaliplatin resistance in colorectal cancer patients and human cell lines
A. Ginés , E. Martinez-Balibrea , C. Plasencia , A. Martinez-Cardus
Journal of Clinical Oncology 26 4121 -4121
1
2008
Copper (Cu) transporter ATP7B mRNA levels as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil (5FU) plus oxaliplatin combination
E. Martinez-Balibrea , C. Plasencia , A. Martinez-Cardus , I. Ojanguren
Journal of Clinical Oncology 23 9603 -9603
1
2005
3036 POSTER Tipification of genes related to oxaliplatin (OXA) sensitivity in a panel of 14 human colorectal cancer (CRC) cell lines by using microarray technology and real time quantitative PCR (QRTPCR)
A. Martinez-Cardus , E. Martinez-Balibrea , E. Bandrés , R. Malumbres
Ejc Supplements 5 ( 4) 246
2007
P54 Study of ATP7B copper transporter mRNA levels as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin
A. Martinez-Cardus , E. Martinez-Balibrea , A. Gines , J.L. Manzano
Ejc Supplements 5 ( 8) 29
2007
Gene expression profile related to oxaliplatin resistance in a panel of sensitive human colorectal cancer cell lines with acquired resistance to the drug
A. Martinez-Cardus , E. Martinez-Balibrea , J. L. Manzano , E. Bandres
Journal of Clinical Oncology 24 13143 -13143
2
2006
Predictive value of single nucleotide polymorphisms (SNPs) in DNA repair genes in non-selected advanced colorectal cancer (CRC) patients (p) treated with oxaliplatin (OXA) plus 5-Fluorouracil (5-FU) first-line chemotherapy (CT)
E. Martinez-Balibrea , J. L. Manzano , S. Catot , A. Martinez-Cardus
Journal of Clinical Oncology 22 3680 -3680
1
2004
6121 Gene expression profile related to oxaliplatin (OXA) intrinsic resistance in a panel of 14 human colorectal cancer (CRC) cell lines
A. Martinez-Cardus , E. Martinez-Balibrea , E. Bandrés , R. Malumbres
Ejc Supplements 7 ( 2) 359
2009
Pharmacogenetic approach for capecitabine or 5-fluorouracil (5FU) selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer
E. Martinez-Balibrea , A. Abad , E. Aranda , J. Sastre
Journal of Clinical Oncology 26 4132 -4132
2008
Erratum: gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis
C Anadon , S Guil , L Simo-Riudalbas , C Moutinho
Oncogene 35 ( 33) 4422 -4422
12
2016
BRAF-V600E Driven Mutations in Grade 3 Neuroendocrine Carcinomas of Colon Origin: Results from Genomic/Epigenomic Profilings and Patient-Derived Mouse Model
J Capdevila , F Mancuso , S Landolfi , A Martinez-Cardus
NEUROENDOCRINOLOGY 106 25 -25
1
2018
Curcumin-mediated oxaliplatin resistance reversal in CRC cell lines through modulation of NF-kB, STAT3 and CDK5 signaling pathways
V Ruiz de Porras , A Gines , S Vallejo , A Martinez-Cardus
EUROPEAN JOURNAL OF CANCER 49 S172 -S172
2013
Epigenetic biomarkers of chemoresistance in colorectal cancer
Cátia Moutinho , Anna Martinez-Cardús , Eva Martínez-Balibrea , Albert Abad
Cancer Research 72 ( 8_Supplement) 835 -835
2012
TYMS and XRCC1 gene polymorphisms as possible predictors for the addition of oxaliplatin to 5FU in the adjuvant treatment of stage II and III colorectal cancer
Eva Martinez-Balibrea , Albert Abad , Anna Martinez-Cardús , Alba Ginés
Cancer Research 70 ( 8_Supplement) 2610 -2610
2010
Role of Pyruvate Kinase isozyme type M2 in response and resistance to oxaliplatin in HT29 human colon adenocarcinoma cell lines
Alba Ginés , Eva Martinez-Balibrea , Anna Martinez-Cardús , Albert Abad
Cancer Research 70 ( 8_Supplement) 2562 -2562
2010
33P Epigenetic biomarkers ID1, HOXB2 and ATOH8 could predict response to chemotherapy and prognosis in early breast cancer
V Quiroga Garcia , S Moran , C Queralt , S Cabrero
Annals of Oncology 32
2021